PTX
Click for more information
3.61% 4.3¢ prescient therapeutics limited

My understanding of the FDA's stance is that the approval of the...

  1. Dee55Tee
    250 Posts.
    lightbulb Created with Sketch. 84
    clock Created with Sketch.
    04/05/24
    16:41
    Post #: 73666161
    My understanding of the FDA's stance is that the approval of the Registration study will hinge on the outcomes and data from the Phase 2 study. SYC has indicated that results from the study will be consistently disclosed, and that extensive preparations, including the manufacturing processes required for Registration approval, have been undertaken.
    PTX Price at posting: 4.6¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
RZI https://hotcopper.com.au/news/asx-news/149063/fast-track-assaying-yields-182-g-t-gold-for-itech-at-new-nt-play/
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.3¢ 		Change
0.002(3.61%) 		Mkt cap ! $34.62M
Open High Low Value Volume
4.2¢ 4.3¢ 4.1¢ $14.70K 349.5K

Buyers (Bids)

No. Vol. Price($)
1 15222 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 20003 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.